BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 31792123)

  • 21. Favorable outcome in non-infant children with MLL-AF4-positive acute lymphoblastic leukemia: a report from the Tokyo Children's Cancer Study Group.
    Tomizawa D; Kato M; Takahashi H; Fujimura J; Inukai T; Fukushima T; Kiyokawa N; Koh K; Manabe A; Ohara A
    Int J Hematol; 2015 Nov; 102(5):602-10. PubMed ID: 26410102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ETO2-GLIS2: A Chimeric Transcription Factor Drives Leukemogenesis through a Neomorphic Transcription Network.
    Wheat JC; Steidl U
    Cancer Cell; 2017 Mar; 31(3):307-308. PubMed ID: 28292433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the acute myeloid leukemia--associated fusion proteins on nuclear architecture.
    Faretta M; Di Croce L; Pelicci PG
    Semin Hematol; 2001 Jan; 38(1):42-53. PubMed ID: 11172539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crizotinib treatment for refractory pediatric acute myeloid leukemia with RAN-binding protein 2-anaplastic lymphoma kinase fusion gene.
    Hayashi A; Tanoshima R; Tsujimoto SI; Yanagimachi M; Takeuchi M; Sasaki K; Ikeda J; Kajiwara R; Ito S; Takahashi H
    Blood Cancer J; 2016 Aug; 6(8):e456. PubMed ID: 27494825
    [No Abstract]   [Full Text] [Related]  

  • 25. EWSR1/ELF5 induces acute myeloid leukemia by inhibiting p53/p21 pathway.
    Endo A; Tomizawa D; Aoki Y; Morio T; Mizutani S; Takagi M
    Cancer Sci; 2016 Dec; 107(12):1745-1754. PubMed ID: 27627705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myeloid translocation gene CBFA2T3 directs a relapse gene program and determines patient-specific outcomes in AML.
    Steinauer N; Guo C; Huang C; Wong M; Tu Y; Freter CE; Zhang J
    Blood Adv; 2019 May; 3(9):1379-1393. PubMed ID: 31040112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The applicability of multiparameter flow cytometry for the detection of minimal residual disease using different-from-normal panels to predict relapse in patients with acute myeloid leukemia after allogeneic transplantation.
    Wang Z; Guo M; Zhang Y; Xu S; Cheng H; Wu J; Zhang W; Hu X; Yang J; Wang J; Tang G
    Int J Lab Hematol; 2019 Oct; 41(5):607-614. PubMed ID: 31162830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TAF15-ZNF384 fusion gene in childhood mixed phenotype acute leukemia.
    Yao L; Cen J; Pan J; Liu D; Wang Y; Chen Z; Ruan C; Chen S
    Cancer Genet; 2017 Feb; 211():1-4. PubMed ID: 28279306
    [No Abstract]   [Full Text] [Related]  

  • 29. Chronic versus acute myelogenous leukemia: a question of self-renewal.
    Jamieson CH; Weissman IL; Passegué E
    Cancer Cell; 2004 Dec; 6(6):531-3. PubMed ID: 15607956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemia.
    Oberley MJ; Gaynon PS; Bhojwani D; Pulsipher MA; Gardner RA; Hiemenz MC; Ji J; Han J; O'Gorman MRG; Wayne AS; Raca G
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27265. PubMed ID: 29797659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiplex reverse transcription-polymerase chain reaction as diagnostic molecular screening of 4 common fusion chimeric genes in Taiwanese children with acute lymphoblastic leukemia.
    Yang YL; Lin SR; Chen JS; Hsiao CC; Lin KH; Sheen JM; Cheng CN; Wu KH; Lin SW; Yu SL; Chen HY; Lu MY; Chang HH; Yen CT; Lin JF; Su YH; Li YP; Lin CY; Jou ST; Lin DT
    J Pediatr Hematol Oncol; 2010 Nov; 32(8):e323-30. PubMed ID: 20930648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia.
    Somervaille TC; Cleary ML
    Cancer Cell; 2006 Oct; 10(4):257-68. PubMed ID: 17045204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular methods used for detection of minimal residual disease following hematopoietic stem cell transplantation in myeloid disorders.
    Elmaagacli AH
    Methods Mol Biol; 2014; 1109():187-207. PubMed ID: 24473785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular genetics in acute leukemia.
    Rowley JD
    Leukemia; 2000 Mar; 14(3):513-7. PubMed ID: 10720153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of myeloablative allogeneic hematopoietic stem cell transplantation in adult patients with MLL-ELL-positive acute myeloid leukemia.
    Muto T; Takeuchi M; Yamazaki A; Sugita Y; Tsukamoto S; Sakai S; Takeda Y; Mimura N; Ohwada C; Sakaida E; Aotsuka N; Iseki T; Nakaseko C
    Int J Hematol; 2015 Jul; 102(1):86-92. PubMed ID: 25758097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Pluripotency Regulator PRDM14 Requires Hematopoietic Regulator CBFA2T3 to Initiate Leukemia in Mice.
    Tracey LJ; Brooke-Bisschop T; Jansen PWTC; Campos EI; Vermeulen M; Justice MJ
    Mol Cancer Res; 2019 Jul; 17(7):1468-1479. PubMed ID: 31015254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation.
    Qin YZ; Wang Y; Zhu HH; Gale RP; Zhang MJ; Jiang Q; Jiang H; Xu LP; Chen H; Zhang XH; Liu YR; Lai YY; Jiang B; Liu KY; Huang XJ
    Chin J Cancer; 2016 May; 35():46. PubMed ID: 27197573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allogeneic haematopoietic stem cell transplantation for infant acute lymphoblastic leukaemia with KMT2A (MLL) rearrangements: a retrospective study from the paediatric acute lymphoblastic leukaemia working group of the Japan Society for Haematopoietic Cell Transplantation.
    Kato M; Hasegawa D; Koh K; Kato K; Takita J; Inagaki J; Yabe H; Goto H; Adachi S; Hayakawa A; Takeshita Y; Sawada A; Atsuta Y; Kato K
    Br J Haematol; 2015 Feb; 168(4):564-70. PubMed ID: 25302748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation.
    Mattsson J; Uzunel M; Tammik L; Aschan J; Ringdén O
    Leukemia; 2001 Dec; 15(12):1976-85. PubMed ID: 11753621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hematopoietic transformation in the absence of MLL1/KMT2A: distinctions in target gene reactivation.
    Chen Y; Ernst P
    Cell Cycle; 2019 Jul; 18(14):1525-1531. PubMed ID: 31161857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.